CH Biotech R&D Co., Ltd.

Equities

6534

TW0006534001

Agricultural Chemicals

End-of-day quote Taiwan S.E. Other stock markets 2024-09-16			5-day change	1st Jan Change
73.80 ^TWD	0.00%		0.00%	-8.32%

Aug. 12	CH Biotech R&D Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
Aug. 06	CH Biotech Books Attributable Profit of NT$549.2 Million in Q2	MT

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about CH Biotech R&D Co., Ltd.

CH Biotech R&D Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	Aug. 11	CI
CH Biotech Books Attributable Profit of NT$549.2 Million in Q2	Aug. 06	MT
Ch Biotech R&D Co., Ltd. Approves Dividend Distribution for the First Half Year of 2024, Payable on September 19, 2024	Aug. 06	CI
Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members	May. 21	CI
CH Biotech R&D Co., Ltd. Announces Audit Committee Changes	May. 21	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index	Mar. 06	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Second Half of 2023, Payable on April 12, 2024	Feb. 27	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the First Half Ended June 30, 2023, Payable on October 18, 2023	23-08-08	CI
CH Biotech R&D Co., Ltd. Appoints Robert James Christopher Clayton as Institutional Director Representative	23-05-24	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
CH Biotech R&D Co., Ltd. Announces Resignation of Brent Randall Smith as Natural-Person Director	23-03-12	CI
CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director	23-03-02	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Year Ended December 31, 2022, Payable on April 10, 2023	23-02-21	CI
CH Biotech R&D Co., Ltd.(TPEX:6534) added to S&P Global BMI Index	22-09-19	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-01	CI
Ch Biotech R&D Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-13	CI
Ch Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Ch Biotech R&D Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-12	CI